Par Drugs & Chemicals Ltd
Healthcare | Small Cap
Par Drugs & Chemicals Ltd showcases a very strong financial profile, marked by exceptional profitability and a complete absence of debt. This debt-free status provides remarkable financial stability and insulates it from risks associated with interest payments. The company's ability to meet its short-term financial obligations is also excellent, indicating a high level of liquidity. Growth has been robust in terms of sales and overall earnings, suggesting successful business expansion. However, the company's operational efficiency presents a mixed picture; while it manages its inventory superbly, it appears to be underutilizing its fixed assets and capital to generate sales. A key point for investors is that the company does not pay dividends, retaining earnings for growth. The future outlook appears positive, supported by strong profits and a secure financial base, though a decline in operating profit growth points to potential margin pressures.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsUndervalued
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio8.80
- Financial Ratio6.80
- Profitability Ratio10.00
- Efficiency Ratio6.00
- Coverage Ratio2.00
- Solvency Ratio10.00
- Liquidity Ratio8.80
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBearish
- 2 HoursNeutral
- 4 HoursBullish
- 1 DayBullish
- 1 WeekNeutral
- 1 MonthBearish
Par Drugs & Chemicals Ltd showcases a very strong financial profile, marked by exceptional profitability and a complete absence of debt. This debt-free status provides remarkable financial stability and insulates it from risks associated with interest payments. The company's ability to meet its short-term financial obligations is also excellent, indicating a high level of liquidity. Growth has been robust in terms of sales and overall earnings, suggesting successful business expansion. However, the company's operational efficiency presents a mixed picture; while it manages its inventory superbly, it appears to be underutilizing its fixed assets and capital to generate sales. A key point for investors is that the company does not pay dividends, retaining earnings for growth. The future outlook appears positive, supported by strong profits and a secure financial base, though a decline in operating profit growth points to potential margin pressures.
Overall Valuation Score
P/E RATIO (TTM)
8.88
Industry Median
32.23
Small Cap Median
32.23
P/E RATIO
8.88
P/B RATIO
1.04
Industry Median
0.86
Small Cap Median
0.86
P/S RATIO
1.12
Industry Median
20.27
Small Cap Median
20.27
Others
PEG RATIO
1.64
EV/EBITDA RATIO
3.55
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹94.6 as on Jun 19, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company presents a strong but somewhat contradictory growth picture. It has achieved excellent growth in revenues, assets, and bottom-line profits, which is very positive for its long-term prospects and shareholder value. However, a significant concern is the decline in operating profit. This suggests that while the company is getting bigger and selling more, the profitability of its core business operations is being squeezed, possibly due to rising costs or competitive pressures. This divergence warrants attention as it could impact future overall profitability.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 22.95 | 28 | 0 | 5.21 | 2.97 |
| Operating Profit Growth Rate | 0 | 12.5 | 27.78 | -13.04 | -15 |
| Earnings Per Share (EPS) Growth | -20.66 | 22.96 | 27.9 | -7.81 | -1.93 |
| Asset Growth Rate | 3.95 | 12.66 | 14.61 | 16.67 | 8.4 |
| Net Income Growth Rate | -25 | 22.22 | 27.27 | -7.14 | 0 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial standing from a shareholder's viewpoint is generally good. It is delivering solid growth in its earnings and intrinsic value per share, which is positive for investors' wealth. Capital spending is also being managed prudently. The main drawback for some investors would be the complete lack of dividends, as returns are based solely on potential share price increases. Additionally, its cash earnings are not as strong as its reported profits, suggesting some earnings are tied up in non-cash accounting items.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 7.5 | 9.08 | 11.66 | 10.18 | 10.83 |
| Cash Earnings Per Share (Cash EPS) | 10 | 11.67 | 14.17 | 14.17 | 14.17 |
| Book Value Per Share | 50 | 59.17 | 70.83 | 82.5 | 93.33 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 3.2 | 7.4 | 6.1 | 1.2 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability is outstanding in every respect. It is highly effective at turning sales into profit at all stages, from gross margin down to the final net profit. Furthermore, it generates excellent returns on the investments made by both its shareholders and its overall capital base. This indicates superior management, strong pricing power, and efficient cost control. This all-around strength in profitability is a core pillar of the company's financial health and a very positive sign for its long-term success.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 17.33 | 15.62 | 20.83 | 15.84 | 12.5 |
| Return on Capital Employed (ROCE) | 22 | 23 | 25 | 18 | 17 |
| Return on Equity (ROE) | 15 | 15.49 | 16.47 | 13.13 | 11.61 |
| Return on Assets (ROA) | 20.25 | 20.22 | 22.55 | 16.81 | 13.18 |
| Operating Margin | 21.33 | 18.75 | 23.96 | 19.8 | 16.35 |
| Net Margin | 12 | 11.46 | 14.58 | 12.87 | 12.5 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's operational efficiency is a mixed story. On the one hand, it excels at managing its inventory, selling products quickly and minimizing storage time, which is very positive. On the other hand, it struggles to generate sufficient sales from its investments in fixed assets and overall capital. This suggests that while the company is good at handling its goods, its larger investments in plant and equipment are not working as hard as they could be. The speed of collecting payments from customers is average.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 2.21 | 2.53 | 2.34 | 2.59 | 2.89 |
| Inventory Turnover Ratio | 16.08 | 16.06 | 15.9 | 16.52 | 15.85 |
| Receivables Turnover Ratio | 4.85 | 5.42 | 6.26 | 6.64 | 7.24 |
| Days Sales in Inventory Ratio | 22.7 | 22.73 | 22.96 | 22.09 | 23.03 |
| Receivable Days | 75.26 | 67.34 | 58.31 | 54.97 | 50.41 |
| Capital Turnover Ratio | 1.25 | 1.35 | 1.13 | 1.02 | 0.93 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's low score in this area is misleading. The Interest Coverage ratio is low simply because the company has no debt and therefore no interest to pay—a sign of strength, not weakness. Similarly, the dividend coverage score is low because the company does not currently pay dividends to its shareholders. For an investor seeking regular income, this is a negative. However, for the company's financial health, it means that all profits are retained within the business to fund growth and strengthen its financial position.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | N/A | N/A | N/A | N/A | N/A |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's long-term financial stability is perfect. It operates entirely without debt, meaning it is funded completely by the owners' capital (equity). This is an extremely safe and low-risk financial structure. The company is not beholden to any lenders and faces zero risk of defaulting on debt payments. This total independence provides maximum stability. The only potential downside is that the company is not using financial leverage, a tool that can sometimes be used to increase shareholder returns, but this conservative approach ensures its long-term survival.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0 | 0 | 0 | 0 | 0 |
| Debt to Equity Ratio | 0 | 0 | 0 | 0 | 0 |
| Equity Ratio | 1 | 1 | 1 | 1 | 1 |
| Debt To Asset Ratio | 0 | 0 | 0 | 0 | 0 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company demonstrates an exceptionally strong ability to meet its short-term obligations, indicating very low financial risk in the immediate future. Its holdings of cash and other assets that can be quickly converted to cash are more than sufficient to cover its current debts. This is a significant positive, showcasing financial prudence and stability. A minor point of consideration is that this strong position is less supported by cash generated from ongoing operations and more by the assets it holds on its books. Overall, the company is in a very safe position regarding its short-term financial health.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 2.32 | 2.78 | 3.75 | 2.75 | 3.82 |
| Quick Ratio | 2.07 | 2.48 | 3.49 | 2.44 | 3.51 |
| Cash Ratio | 0.85 | 1.24 | 2.29 | 1.38 | 2.46 |
| Operating Cash Flow Ratio | 0.42 | 0.72 | 1.25 | 0.8 | 0 |
Current Ratios
Quick Ratios
Cash Ratios
Operating Cash Flow Ratios
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Par Drugs & Chemicals Ltd | 7.40 | 8.88 | Undervalued | 17.00 | 10.65 | 13.00 |
| 2 | Vaishali Pharma Ltd | 6.74 | 103.62 | Overvalued | 4.00 | 0.31 | 4.00 |
| 3 | Quest Laboratories Ltd | 5.27 | 11.21 | Neutral | 18.00 | 9.16 | 15.00 |
| 4 | Sotac Pharmaceuticals Ltd | 5.27 | 21.26 | Neutral | 18.00 | 4.45 | 6.00 |
| 5 | Zenith Drugs Ltd | 4.63 | 7.52 | Neutral | 17.00 | 2.30 | 10.00 |
| 6 | Lasa Supergenerics Ltd | 4.39 | -2.61 | Highly Undervalued | -7.00 | -6.80 | -34.00 |
| 7 | Krebs Biochemicals & Industries Ltd | 4.16 | -5.27 | Highly Undervalued | -4.00 | -12.49 | -4.00 |
Management exhibits a mixed performance. Strengths are evident in financial prudence, achieving a debt-free status and maintaining a strong ROCE above 20%. The high and stable promoter holding of over 74% signifies strong conviction. However, these positives are counterbalanced by significant weaknesses. The company shows highly volatile and recently slowing growth in sales and profits, indicating operational instability. Working capital management has deteriorated, with a sharp increase in the cash conversion cycle. Furthermore, the negligible institutional investment and inconsistent dividend policy suggest a lack of broader market confidence and a weak approach to shareholder returns.
Financial Performance & Growth
The company's financial performance is characterized by significant volatility and a recent slowdown. While long-term compounded sales (10Y: 12%) and profit (10Y: 41%) growth appear strong, recent figures show a marked deceleration (3Y Sales Growth: 3%, 3Y Profit Growth: 5%). Annual sales growth turned negative in FY24 (-0.11%) after two years of strong performance. The core issue is the extreme inconsistency in quarterly earnings. YOY profit growth has fluctuated wildly, with figures like +75.87% (Sep 2024) followed by -83.04% (Dec 2024). This level of volatility in both revenue and profit indicates a lack of stable operational control. Although margins (OPM) recovered in FY24, the erratic top-line and bottom-line performance is a significant concern.
| Metric | 2022 | 2023 | 2024 | Compounded (3Y) |
|---|---|---|---|---|
| Annual Sales Growth (%) | 23.57% | 27.55% | -0.11% | 3% |
| Annual Profit Growth (%) | -8.63% | 21.82% | 29.14% | 5% |
Capital Efficiency & Returns
Capital efficiency presents a mixed picture. On one hand, management has consistently delivered strong returns on capital employed (ROCE). The ROCE has remained robust, standing at 25% in the latest fiscal year, and has been consistently above 20% in recent years. This demonstrates effective use of capital in generating profits from core operations. However, this strength is significantly undermined by deteriorating working capital management. The Cash Conversion Cycle (CCC) has worsened considerably, increasing from 14 days in FY22 to 40 days in both FY23 and FY24. This indicates that more cash is being tied up in operations for longer periods, reflecting inefficiency. While the Return on Equity (ROE) is decent (Current: 14.47%), the negative trend in the CCC is a clear weakness.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| ROCE (%) | 25% | 22% | 23% | 25% |
| Cash Conversion Cycle (Days) | 13 | 14 | 40 | 40 |
Financial Health & Prudence
The company's financial health is excellent. The most significant achievement is the complete elimination of debt from the balance sheet. Borrowings have been reduced from ₹8 crores in March 2021 to zero by March 2022, and the company has maintained this debt-free status since. This deleveraging demonstrates strong financial discipline and significantly reduces financial risk. Consequently, the interest coverage ratio is exceptionally high. The enterprise value being lower than the market capitalization, due to a healthy net cash position of ₹37 crores as of March 2024, further reinforces the strength of the balance sheet. This prudent capital structure provides the company with a solid financial foundation and flexibility. The only minor drawback is the inconsistent dividend policy, but the overall financial prudence is outstanding.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Borrowings (₹ Cr) | 6 | 8 | 0 | 0 | 0 |
Shareholding & Ownership Structure
The shareholding structure presents a stark contrast between promoter conviction and institutional interest. A major strength is the high and stable promoter holding, which stood at 74.21% as of March 2024. This indicates a strong alignment of the management's interests with those of the company and a long-term commitment. However, a glaring weakness is the almost non-existent holding by institutional investors. The combined holding of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) was a mere 0.12% in March 2024. This extremely low participation suggests that the company has not yet attracted the confidence of large, sophisticated investors. While the high promoter stake is a positive, the lack of institutional validation is a considerable negative.
| Shareholder Category | Holding (Mar 2024) |
|---|---|
| Promoter Holding | 74.21% |
| FII Holding | 0.07% |
| DII Holding | 0.05% |
| Public Holding | 25.68% |
The primary risk is the severe volatility in the company's operational performance. Extreme fluctuations in quarterly sales and profit growth indicate a high degree of business uncertainty and a lack of predictable earnings. This operational instability likely contributes to the negligible interest from institutional investors. While these risks are substantial, they are partly mitigated by an exceptionally strong and prudent balance sheet. The company is debt-free and has a healthy cash position, which provides a cushion against operational shocks. The accounting quality also appears sound. The risk assessment is therefore balanced between operational volatility (high risk) and financial stability (low risk).
Accounting Quality
A key positive indicator is that cash flow from operations (CFO) has consistently been strong and, in recent years, has exceeded net profit. For FY2024, CFO was ₹20 crore against a net profit of ₹14 crore. Similarly, in FY2023, CFO was ₹13 crore against a net profit of ₹11 crore. This demonstrates that the company's reported profits are being effectively converted into actual cash, which is a sign of high-quality earnings. Furthermore, the company's enterprise value is lower than its market cap due to a substantial net cash position, reinforcing a healthy financial state.
Operational Performance Volatility
The company exhibits extremely high performance volatility, which is a major risk factor. Its quarterly results show a pattern of erratic and unpredictable growth. The year-over-year profit growth swings dramatically from one quarter to the next, as seen in the data. This inconsistency makes it difficult to forecast future performance and suggests potential issues with demand stability, production planning, or pricing power. The inability to deliver consistent growth, even on a quarterly basis, points to a high level of inherent business risk.
| Quarter (YOY Profit Growth %) | Value |
|---|---|
| Sep 2024 | +75.87% |
| Dec 2024 | -83.04% |
| Sep 2025 | -51.98% |
| Dec 2025 | +727.59% |
| Mar 2026 | -48.48% |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1095.24Bearish
- SMA 2095.21Bearish
- SMA 5092.31Bullish
- EMA 1095.07Bearish
- EMA 2094.83Bullish
- EMA 5093.07Bullish
- DEMA 1095.00Bearish
- DEMA 2095.75Bearish
- DEMA 5095.56Bearish
- TEMA 1094.71Bullish
- TEMA 2095.15Bearish
- TEMA 5096.64Bearish
- MACD0.57Bearish
- ADX23.96Weak Trend
- IndicatorValueSignal
- RSI53.78Neutral
- CCI-57.46Neutral
- ROC 9-1.30Bearish
- ROC 14-0.04Bearish
- ROC 251.00Bullish
- Stoch K47.12Neutral
- Stoch D45.77Neutral
- IndicatorValueSignal
- BB Upper96.50Neutral
- BB Middle95.21Neutral
- BB Lower93.91Neutral
- ATR1.26Low Volatility
- IndicatorValueSignal
- MFI39.98Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1095.33Bearish
- SMA 2094.74Bullish
- SMA 5090.21Bullish
- EMA 1094.96Bearish
- EMA 2093.91Bullish
- EMA 5091.63Bullish
- DEMA 1095.59Bearish
- DEMA 2096.06Bearish
- DEMA 5093.78Bullish
- TEMA 1095.00Bearish
- TEMA 2096.33Bearish
- TEMA 5095.61Bearish
- MACD1.52Bearish
- ADX25.07Strong Trend
- IndicatorValueSignal
- RSI57.65Neutral
- CCI-14.75Neutral
- ROC 9-0.03Bearish
- ROC 140.15Bullish
- ROC 2510.59Bullish
- Stoch K47.11Neutral
- Stoch D52.24Neutral
- IndicatorValueSignal
- BB Upper96.53Neutral
- BB Middle94.74Neutral
- BB Lower92.95Neutral
- ATR1.84Low Volatility
- IndicatorValueSignal
- MFI59.27Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1094.84Bullish
- SMA 2090.74Bullish
- SMA 5089.07Bullish
- EMA 1094.02Bullish
- EMA 2092.21Bullish
- EMA 5090.51Bullish
- DEMA 1096.12Bearish
- DEMA 2094.64Bullish
- DEMA 5091.57Bullish
- TEMA 1096.36Bearish
- TEMA 2096.26Bearish
- TEMA 50N/AN/A
- MACD1.98Bullish
- ADX23.10Weak Trend
- IndicatorValueSignal
- RSI58.94Neutral
- CCI63.23Neutral
- ROC 91.54Bullish
- ROC 147.64Bullish
- ROC 259.00Bullish
- Stoch K81.82Overbought
- Stoch D84.20Overbought
- IndicatorValueSignal
- BB Upper99.25Neutral
- BB Middle90.74Neutral
- BB Lower82.22Neutral
- ATR2.92Low Volatility
- IndicatorValueSignal
- MFI76.85Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 1090.06Bullish
- SMA 2089.37Bullish
- SMA 5090.45Bullish
- SMA 10090.86Bullish
- SMA 20095.52Bullish
- EMA 1091.61Bullish
- EMA 2090.34Bullish
- EMA 5090.16Bullish
- EMA 10091.60Bullish
- EMA 20098.72Bearish
- DEMA 1093.91Bullish
- DEMA 2091.36Bullish
- DEMA 5089.38Bullish
- DEMA 10087.58Bullish
- DEMA 20079.15Bullish
- TEMA 1095.68Bullish
- TEMA 2092.77Bullish
- TEMA 5090.30Bullish
- TEMA 10090.21Bullish
- TEMA 20086.52Bullish
- MACD1.05Bullish
- ADX15.75Weak Trend
- IndicatorValueSignal
- RSI62.70Neutral
- CCI151.39Overbought
- ROC 148.21Bullish
- ROC 253.64Bullish
- Stoch K83.09Overbought
- Stoch D72.66Neutral
- IndicatorValueSignal
- BB Upper96.55Neutral
- BB Middle89.37Neutral
- BB Lower82.20Neutral
- ATR4.44Low Volatility
- IndicatorValueSignal
- MFI82.88Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
- IndicatorValueSignal
- SMA 2090.24Bearish
- SMA 5095.92Bearish
- EMA 2090.72Bearish
- EMA 50102.11Bearish
- DEMA 2086.99Bearish
- DEMA 5076.82Bullish
- TEMA 2088.70Bearish
- TEMA 5080.91Bullish
- MACD-2.72Bullish
- ADX8.15Weak Trend
- IndicatorValueSignal
- RSI42.98Neutral
- CCI-108.53Oversold
- ROC 14-5.88Bearish
- ROC 25-21.78Bearish
- Stoch K50.98Neutral
- Stoch D46.03Neutral
- IndicatorValueSignal
- BB Upper98.97Neutral
- BB Middle90.24Neutral
- BB Lower81.52Neutral
- ATR8.54Low Volatility
- IndicatorValueSignal
- MFI17.84Oversold
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 690.84Bearish
- SMA 1294.66Bearish
- SMA 24144.68Bearish
- EMA 691.00Bearish
- EMA 12102.12Bearish
- EMA 24126.03Bearish
- DEMA 685.47Bullish
- DEMA 1276.74Bullish
- DEMA 2493.70Bearish
- TEMA 689.25Bearish
- TEMA 1279.57Bullish
- TEMA 2464.99Bullish
- MACD-11.37Bearish
- ADX18.04Weak Trend
- IndicatorValueSignal
- RSI45.32Neutral
- CCI-105.74Oversold
- ROC 25-66.94Bearish
- ROC 50-44.23Bearish
- Stoch K5.63Oversold
- Stoch D21.47Neutral
- IndicatorValueSignal
- BB Upper252.63Neutral
- BB Middle125.17Neutral
- BB Lower-2.29Neutral
- ATR31.48Low Volatility
- IndicatorValueSignal
- MFI67.75Neutral